Lastly, the predictive value of IHC-based PD-L1 expression for immunotherapy response is not definitive, due in part to practical challenges obtaining adequately sized and preserved tumor tissue samples and isolating sufficient quantities of viable tumor cells from limited biopsy specimens (28). The gene discussed is CD274; the disease is neoplasm.